Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe changes appear to be minor UI/layout adjustments between versions, with no alterations to core study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, with no other content changes.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved explicit mentions of Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs; overall content framing in the safety/quality area appears diminished.SummaryDifference0.2%

- Check54 days agoChange DetectedUpdated version from v3.0.1 to v3.0.2; removed the Back to Top element. No changes to core content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.